X-67545316-TGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCA-TGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCA

Variant summary

Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP3BP6_Very_StrongBA1

The NM_000044.6(AR):​c.237_239dupGCA​(p.Gln80dup) variant causes a disruptive inframe insertion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0394 in 989,447 control chromosomes in the GnomAD database, including 2,419 homozygotes. There are 8,985 hemizygotes in GnomAD. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. Q80Q) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.081 ( 446 hom., 389 hem., cov: 0)
Exomes 𝑓: 0.036 ( 1973 hom. 8596 hem. )

Consequence

AR
NM_000044.6 disruptive_inframe_insertion

Scores

Not classified

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: 0.337

Publications

10 publications found
Variant links:
Genes affected
AR (HGNC:644): (androgen receptor) The androgen receptor gene is more than 90 kb long and codes for a protein that has 3 major functional domains: the N-terminal domain, DNA-binding domain, and androgen-binding domain. The protein functions as a steroid-hormone activated transcription factor. Upon binding the hormone ligand, the receptor dissociates from accessory proteins, translocates into the nucleus, dimerizes, and then stimulates transcription of androgen responsive genes. This gene contains 2 polymorphic trinucleotide repeat segments that encode polyglutamine and polyglycine tracts in the N-terminal transactivation domain of its protein. Expansion of the polyglutamine tract from the normal 9-34 repeats to the pathogenic 38-62 repeats causes spinal bulbar muscular atrophy (SBMA, also known as Kennedy's disease). Mutations in this gene are also associated with complete androgen insensitivity (CAIS). Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jan 2017]
AR Gene-Disease associations (from GenCC):
  • androgen insensitivity syndrome
    Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine
  • Kennedy disease
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, ClinGen, G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • partial androgen insensitivity syndrome
    Inheritance: XL Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp
  • complete androgen insensitivity syndrome
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -17 ACMG points.

BP3
Nonframeshift variant in repetitive region in NM_000044.6
BP6
Variant X-67545316-T-TGCA is Benign according to our data. Variant chrX-67545316-T-TGCA is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 434257.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.106 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ARNM_000044.6 linkc.237_239dupGCA p.Gln80dup disruptive_inframe_insertion Exon 1 of 8 ENST00000374690.9 NP_000035.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ARENST00000374690.9 linkc.237_239dupGCA p.Gln80dup disruptive_inframe_insertion Exon 1 of 8 1 NM_000044.6 ENSP00000363822.3 P10275-1

Frequencies

GnomAD3 genomes
AF:
0.0809
AC:
5386
AN:
66566
Hom.:
446
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.0554
Gnomad AMI
AF:
0.0968
Gnomad AMR
AF:
0.113
Gnomad ASJ
AF:
0.0945
Gnomad EAS
AF:
0.102
Gnomad SAS
AF:
0.0892
Gnomad FIN
AF:
0.0822
Gnomad MID
AF:
0.124
Gnomad NFE
AF:
0.0875
Gnomad OTH
AF:
0.0773
GnomAD4 exome
AF:
0.0364
AC:
33556
AN:
922896
Hom.:
1973
Cov.:
40
AF XY:
0.0304
AC XY:
8596
AN XY:
282430
show subpopulations
African (AFR)
AF:
0.0257
AC:
606
AN:
23591
American (AMR)
AF:
0.0745
AC:
1882
AN:
25247
Ashkenazi Jewish (ASJ)
AF:
0.0539
AC:
851
AN:
15792
East Asian (EAS)
AF:
0.109
AC:
2956
AN:
27130
South Asian (SAS)
AF:
0.0664
AC:
2854
AN:
42982
European-Finnish (FIN)
AF:
0.0949
AC:
3384
AN:
35673
Middle Eastern (MID)
AF:
0.0572
AC:
143
AN:
2502
European-Non Finnish (NFE)
AF:
0.0266
AC:
18924
AN:
710836
Other (OTH)
AF:
0.0500
AC:
1956
AN:
39143
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.415
Heterozygous variant carriers
0
1142
2284
3427
4569
5711
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
132
264
396
528
660
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0809
AC:
5384
AN:
66551
Hom.:
446
Cov.:
0
AF XY:
0.0471
AC XY:
389
AN XY:
8253
show subpopulations
African (AFR)
AF:
0.0553
AC:
1039
AN:
18777
American (AMR)
AF:
0.113
AC:
592
AN:
5223
Ashkenazi Jewish (ASJ)
AF:
0.0945
AC:
162
AN:
1715
East Asian (EAS)
AF:
0.103
AC:
190
AN:
1839
South Asian (SAS)
AF:
0.0903
AC:
81
AN:
897
European-Finnish (FIN)
AF:
0.0822
AC:
166
AN:
2020
Middle Eastern (MID)
AF:
0.105
AC:
14
AN:
133
European-Non Finnish (NFE)
AF:
0.0875
AC:
3035
AN:
34691
Other (OTH)
AF:
0.0764
AC:
62
AN:
812
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
190
379
569
758
948
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
48
96
144
192
240
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0250
Hom.:
237

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:11
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:6
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Aug 19, 2016
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 04, 2022
Mendelics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 03, 2020
Genomic Research Center, Shahid Beheshti University of Medical Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Feb 16, 2025
Laboratory of Genetics, Children's Clinical University Hospital Latvia
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:4
Jul 13, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Oct 01, 2016
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Department of Pathology and Laboratory Medicine, Sinai Health System
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

The AR p.Gln80dup variant was not identified in the literature but was identified in dbSNP (ID: rs3032358). The variant was identified in ClinVar (reported by Invitae as benign for Androgen resistance syndrome and Bulbo-spinal atrophy X-linked, and reported likely benign by Genetics Services Laboratory University of Chicago), Clinvitae, Cosmic (identified in neck tissue from squamous cell carcinoma cells) and LOVD 3.0 (predicted to be benign). The variant was not identified in the following control databases: the 1000 Genomes Project, the NHLBI GO Exome Sequencing Project, the Exome Aggregation Consortium (August 8th 2016), or the Genome Aggregation Database (Feb 27, 2017). This variant is an in-frame insertion resulting in the duplication of a glutamine (gln) residue at codon 80; the impact of this alteration on AR protein function is not known, however this insertion occurs in a variable poly-Q repeat region and was predicted to be a polymorphism by MutationTaster. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time although we would lean towards a more benign role for this variant. This variant is classified as likely benign. -

Androgen resistance syndrome;C1839259:Kennedy disease Benign:1
Dec 24, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
0.34
Mutation Taster
=69/31
polymorphism (auto)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3032358; hg19: chrX-66765158; COSMIC: COSV65952534; API